Literature DB >> 33928494

Screening for inhibitory effects of crude drugs on furin-like enzymatic activities.

Yuka Kiba1, Rio Oyama2, Sae Misawa2, Takashi Tanikawa3, Masashi Kitamura4, Ryuichiro Suzuki5.   

Abstract

The spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contains a cleavage motif R-X-X-R for furin-like enzymes at the boundary of the S1/S2 subunits. The cleavage of the site by cellular proteases is essential for S protein activation and virus entry. We screened the inhibitory effects of crude drugs on in vitro furin-like enzymatic activities using a fluorogenic substrate with whole-cell lysates. Of the 124 crude drugs listed in the Japanese Pharmacopeia, aqueous ethanolic extract of Cnidii Monnieris Fructus, which is the dried fruit of Cnidium monnieri Cussion, significantly inhibited the furin-like enzymatic activities. We further fractionated the plant extract and isolated the two active compounds with the inhibitory activity, namely, imperatorin and osthole, whose IC50 values were 1.45 mM and 9.45 µM, respectively. Our results indicated that Cnidii Monnieris Fructus might exert inhibitory effects on furin-like enzymatic activities, and that imperatorin and osthole of the crude drug could be potential inhibitors of the motif cleavage.
© 2021. The Japanese Society of Pharmacognosy.

Entities:  

Keywords:  Coumarin; Furin; Imperatorin; Osthole; Proprotein convertase; SARS-CoV-2

Mesh:

Substances:

Year:  2021        PMID: 33928494      PMCID: PMC8084592          DOI: 10.1007/s11418-021-01519-9

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


Introduction

In December 2019, a novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), belonging to the human coronavirus family, was identified in Hubei Province, China [1]. It causes coronavirus disease 2019 (COVID-19), a severe respiratory disease associated with a high mortality rate. According to the World Health Organization 2019 situation report of February 16, 2021, more than 100,000,000 patients have been diagnosed with COVID-19 and 2,300,000 have died worldwide. The entry of coronavirus into host cells is mediated by the spike (S) protein [2]. Processing of the S protein by cellular proteases, such as transmembrane protease serine 2 (TMPRSS2), cathepsin, and furin is necessary for protein activation and virus entry [3]. The S protein of SARS-CoV-2 consists of the NH2-terminal S1 domain and COOH-terminal S2 domain [2, 3]. The S1 domain has a receptor-binding domain (RBD) that binds to the host angiotensin-converting enzyme 2 (ACE2) receptor and the S2 domain has an fusion peptide (FP) domain that mediates membrane fusion. The S protein cleavage at the S1/S2 boundary by host cell protease plays a key role in binding the ACE2 receptor to the S1 domain. The S protein of SARS-CoV2 has a cleavage motif R-X-X-R for furin-like enzymes at the S1/S2 boundary, matching the consensus amino acid motif of the substrate for furin and related proprotein convertases (PCs) [2, 3]. Furin/PC inhibitors block SARS-CoV-2 S protein cleavage to suppress viral entry [2-5]. In addition, SARS-CoV-2 pseudoviruses, which have a mutated S protein at the cleavage site, showed substantially decreased efficiency of entry into host cells [2-4]. Therefore, cleavage inhibitors of the motif site are expected to be therapeutic reagents for SARS-CoV-2 infection [6-8]. Furin, a member of the proprotein convertase family, is ubiquitously expressed in mammalian cells and activates various proprotein substrates [9-11]. Furin regulates not only pathogenic pathways but also several physiological pathways, involving hormones, growth factors, adhesion molecules, and cell surface receptors [12]. Furin is involved in calcium-dependent proteolytic cleavage at the C-terminus of a consensus amino acid motif R-X-X-R↓ (the arrow indicates the cleavage position) [9]. Peptide-based small molecules, such as hexa-D-arginine (D-6R) and chloromethylketone (CMK) have been reported to be inhibitors of furin and other PCs [13-18]. However, furin/PC-targeting therapeutic reagents for clinical application have not been identified to date. Numerous studies have evaluated furin-like (furin and other PCs) enzymatic activities using a fluorogenic substrate with whole cell lysates and tissue homogenates [19-24]. In this study, the inhibitory effects of crude drugs were evaluated using the furin-like protease assay with a fluorescent peptide substrate.

Materials and methods

Materials

We selected 124 crude drugs listed in the Japanese Pharmacopeia, 17th Edition, and purchased them from several distributors (Supplementary Material, Table S1) [25]. Crude drugs (10 g) were refluxed with 300 mL of 70% EtOH for 1 h, and the resultant extracts were dried by evaporation. The samples were dissolved in dimethyl sulfoxide (DMSO) to a concentration of 10 mg/mL and stored at 4 °C until use. Imperatorin and osthole were obtained from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan) and FUJIFILM Wako Pure Chemical Corporation (Osaka, Japan), respectively.

Furin-like enzyme assay

A549 cells, human lung carcinoma epithelial cells, were obtained from RIKEN BioResource Center (Tsukuba, Japan) and cultured in Dulbecco's modified Eagle’s medium containing 10% fetal bovine serum, 100 µg/mL streptomycin, and 100 units/mL penicillin. A549 cells were seeded in 100-mm-diameter dishes (1.0 × 106 cells/plate) and cultured for 24 h at 37 °C with 5% CO2. After 24 h, the cells were washed twice with Dulbecco's phosphate-buffered saline (D-PBS). The washed cells were collected in a 1.5-mL tube by scraping and centrifuging at 2000 × g for 2 min. The cells were counted and treated with 1 mL of 2 × lysis buffer (20 mM HEPES–KOH [pH 7.4], 0.5% Triton X-100, 1 mM CaCl2) per 1.0 × 106 cells. The cell lysates were vortexed for 5 min and centrifuged at 13,000 × g for 10 min at 4 °C. The supernatants were transferred to 1.5-mL tubes and stored at − 80 °C until use. Supernatants (10 µL), crude drug extracts (10 µL), and H2O (70 µL) were added to a 96-well black microplate and incubated at 37 °C for 30 min. Drug extracts were diluted and adjusted to a final concentration of 20 µg/mL for screening. To the mixture, 10 µL of 1 mM Pyr-Arg-Thr-Lys-Arg-methyl-coumaryl-7-amide (pyr-RTKR-MCA) was added (PEPTIDE INSTITUTE, Inc., Osaka, Japan). The mixture was incubated at 37 °C for 30 min, and fluorescence intensity of the sample was measured with excitation at 380 nm and emission at 460 nm using SpectraMax M2 (Molecular Devices, LLC, CA, USA). The 124 samples were subjected to screening using the furin-like enzyme assay, and the results are presented as mean ± standard deviation of at least three independent experiments. Ethylenediaminetetraacetic acid (EDTA, final conc. 50 mM) was used as the control in the assay. Half-maximal inhibitory concentration (IC50) was obtained by logistic regression analysis using the drc package for R [26].

Extraction and isolation of the bioactive compounds

The dried fruits of Cnidii monnieri (100 g) were extracted three times with 70% aqueous EtOH (1 h, each) under reflux, and the solvent was evaporated in vacuo to obtain the corresponding extract (55 g). The extract was suspended in water and fractionated with ethyl acetate three times to obtain an ethyl acetate layer. The water-soluble portion was partitioned with n-BuOH three times. The yield of ethyl acetate soluble extract and n-BuOH soluble extract were 4.7 and 1.2 g, respectively. The ethyl acetate soluble extract (0.3 g) was subjected to chromatography on an ODS column (ODS-SM 50C; Yamazen Corporation, Osaka, Japan) with MeOH–H2O (4:1, v/v) as a solvent to yield 16 fractions. Fraction 4 (12 mg) was chromatographed on a preparative HPLC column (Senshu Pak ODS-4151-N; 10 mm × 150 mm) eluted with MeOH–H2O (2:1, v/v) and monitored at 254 nm to obtain 1 (5.2 mg). Fraction 6 (15 mg) was purified by HPLC (Senshu Pak ODS-4151-N; 10 mm × 150 mm) with MeOH–H2O (2.8:1, v/v) as a solvent, and monitored at 254 nm to obtain 2 (12 mg).

Identification

Compounds 1 and 2 were identified as imperatorin and osthole, respectively. Their structures were confirmed by comparing their spectroscopic data, such as NMR and MS, with those of authentic compounds.

Results and discussion

We screened 124 crude drug extracts for inhibitory effects on furin-like activities. The furin-like activity was evaluated using pyr-RTKR-MCA as a fluorogenic substrate and cell lysates as whole proteolytic enzyme. Of the 124 crude drug extracts, three extracts, Cnidii Monnieris Fructus (dried fruits of C. monnieri), Hydrangeae Dulcis Folium [dried leaves of Hydrangea macrophylla (Thunb.) Ser. var. thunbergii (Siebold) Makino)], and Forsythiae Fructus [dried fruit of Forsythia suspensa (Thunb.) Vahl] suppressed furin-like activities by more than 40% (activity: 6.2% ± 0.3%, 56.5% ± 1.8%, and 42.9% ± 2.3%, respectively) (Table 1). We then evaluated the IC50 of the three samples and Cnidii Rhizome (the dried rhizome of C. officinale) as the control. The IC50 values of Cnidii Monnieris Fructus, Hydrangeae Dulcis Folium, and Forsythiae Fructus were 1.10, 7.12, and 6.52 µg/mL, respectively (Table 2). Cnidii Monnieris Fructus showed stronger inhibitory effects on furin-like activity than Cnidii rhizome (IC50 > 50 µg/mL). Cnidii Monnieri Fructus (Jashoshi in Japanese) has been traditionally used to treat osteoporosis, sexual dysfunction, asthma, and skin ailments [27]. Cnidium monnieri Cusson contains several compounds, such as bergapten, imperatorin, osthole, and xanthotoxin [28]. Here, we fractionated and isolated bioactive compounds from Cnidii Monnieris Fructus contributing to the inhibitory effects on furin-like enzymatic activity. We isolated and identified two coumarin compounds, imperatorin and osthole, with inhibitory activity (Fig. 1). Osthole (IC50 = 9.45 µM) showed significant inhibitory effects on furin-like enzymatic activity when compared with imperatorin (IC50 = 1.45 mM). The autofluorescence of two coumarins (imperatorin and osthole) did not occur because reaction mixture (compounds and substrates) without cell lysates did not show fluorescence signal. These results indicate that Cnidii Monnieris Fructus might inhibit furin-like enzymatic activities, and that imperatorin and osthole of the crude drug could be candidates for inhibitors of motif cleavage.
Table 1

Screening results of the inhibitory effects of 124 crude drugs on furin-like activity

Latin NameFurin-like activity (%)
ACHYRANTHIS RADIX95.2 ± 1.8
ACONITI RADIX PROCESSA72.5 ± 3.6
AKEBIAE CAULIS92.8 ± 1.8
ALISMATIS TUBER101.9 ± 0.7
ALOE83.1 ± 7.9
ALPINIAE OFFICINARI RHIZOMA92.2 ± 1.5
AMOMI SEMEN92.6 ± 2.5
ANEMARRHENAE RHIZOMA95.4 ± 3.4
ANGELICAE ACUTILOBAE RADIX101.8 ± 2.3
ANGELICAE DAHURICAE RADIX99.8 ± 3.1
ARALIAE CORDATAE RHIZOMA60.7 ± 4.2
ARCTII FRUCTUS97.2 ± 4.1
ARECAE SEMEN99.2 ± 2.3
ARMENIACAE SEMEN93.0 ± 9.7
ARTEMISIAE CAPILLARIS FLOS80.0 ± 8.3
ARTEMISIAE FOLIUM79.0 ± 3.8
ASIASARI RADIX78.8 ± 2.7
ASPARAGI RADIX94.2 ± 1.1
ASTRAGALI RADIX92.4 ± 4.6
ATRACTYLODIS LANCEAE RHIZOMA94.4 ± 3.1
ATRACTYLODIS RHIZOMA84.6 ± 3.1
AURANTII FRUCTUS IMMATURUS86.3 ± 2.8
AURANTII PERICARPIUM100.3 ± 3.8
BENINCASAE SEMEN84.7 ± 0.3
BUPLEURI RADIX95.0 ± 2.0
CANNABIS FRUCTUS89.2 ± 1.7
CARTHAMI FLOS93.7 ± 5.3
CASSIAE SEMEN83.6 ± 4.9
CATALPAE FRUCTUS84.8 ± 2.8
CHRYSANTHEMI FLOS85.3 ± 4.9
CIMICIFUGAE RHIZOMA96.4 ± 2.6
CINNAMOMI CORTEX86.9 ± 5.7
CITRI UNSHIU PERICARPIUM80.8 ± 2.7
CLEMATIDIS RADIX85.9 ± 5.6
CNIDII MONNIERIS FRUCTUS6.2 ± 0.3
CNIDII RHIZOMA103.0 ± 3.3
COICIS SEMEN93.0 ± 2.3
COPTIDIS RHIZOMA82.9 ± 7.5
CORNI FRUCTUS89.8 ± 1.8
CORYDALYS TUBER86.5 ± 4.4
CRATAEGI FRUCTUS98.1 ± 2.4
CURCUMAE RHIZOMA78.2 ± 1.5
CYPERI RHIZOMA90.0 ± 0.9
DIGENEA101.1 ± 3.6
DIOSCOREAE RHIZOMA92.1 ± 3.0
EPHEDRAE HERBA86.8 ± 4.7
EPIMEDII HERBA73.4 ± 11.3
ERIOBOTRYAE FOLIUM79.7 ± 3.1
EUODIAE FRUCTUS83.1 ± 2.5
FOENICULI FRUCTUS79.9 ± 11.7
FORSYTHIAE FRUCTUS42.9 ± 2.3
FRITILLARIAE BULBUS90.3 ± 3.0
GARDENIAE FRUCTUS89.0 ± 4.2
GASTRODIA TUBER98.9 ± 2.7
GENTIANAE RADIX101.1 ± 8.1
GENTIANAE SCABRAE RADIX99.6 ± 3.3
GERANII HERBA91.2 ± 12.4
GINSENG RADIX99.5 ± 4.4
GINSENG RADIX RUBRA97.0 ± 1.4
GLYCYRRHIZAE RADIX91.3 ± 4.7
GLYCYRRHIZAE RADIX PRAEPARATA89.3 ± 1.4
HOUTTUYNIAE HERBA92.9 ± 11.7
HYDRANGEAE DULCIS FOLIUM56.5 ± 1.8
KOI95.4 ± 5.3
LEONURI HERBA67.7 ± 6.1
LILII BULBUS99.2 ± 2.6
LINDERAE RADIX67.3 ± 1.3
LITHOSPERMI RADIX92.2 ± 4.4
LONICERAE FOLIUM CUM CAULIS94.6 ± 2.2
LYCII FRUCTUS96.5 ± 4.8
MAGNOLIAE CORTEX95.8 ± 4.9
MAGNOLIAE FLOS99.7 ± 0.5
MALLOTI CORTEX84.2 ± 8.0
MENTHAE HERBA91.1 ± 1.9
MOUTAN CORTEX100.4 ± 2.2
MYRISTICAE SEMEN97.8 ± 0.5
NOTOPTERYGII RHIZOMA95.3 ± 10.3
OPHIOPOGONIS RADIX98.3 ± 1.7
PAEONIAE RADIX95.3 ± 1.6
PANACIS JAPONICI RHIZOMA85.8 ± 2.8
PERILLAE HERBA90.1 ± 1.5
PERSICAE SEMEN95.3 ± 2.7
PEUCEDANI RADIX103.2 ± 5.8
PHARBITIDIS SEMEN79.9 ± 11.2
PHELLODENDRI CORTEX82.1 ± 6.0
PICRASMAE LIGNUM99.4 ± 3.0
PINELLIAE TUBER60.7 ± 3.4
PLANTAGINIS SEMEN98.2 ± 3.6
PLATYCODI RADIX88.7 ± 1.4
POGOSTEMONI HERBA83.9 ± 1.2
POLYGALAE RADIX92.7 ± 3.3
POLYGONATI RHIZOMA87.6 ± 9.7
POLYGONI MULTIFLORI RADIX92.1 ± 6.7
POLYPORUS100.6 ± 1.7
PORIA93.3 ± 2.8
PRUNELLAE SPICA93.9 ± 4.0
PRUNI CORTEX92.2 ± 13.0
PUERARIAE RADIX92.2 ± 6.4
QUERCUS CORTEX97.0 ± 1.7
REHMANNIAE RADIX94.5 ± 1.0
RHEI RHIZOMA88.1 ± 2.6
RYCII CORTEX97.6 ± 4.1
SAPOSHNIKOVIAE RADIX91.9 ± 3.5
SAUSSUREAE RADIX79.2 ± 2.7
SCHISANDRAE FRUCTUS90.4 ± 1.6
SCHIZONEPETAE SPICA85.2 ± 6.6
SCUTELLARIAE RADIX87.1 ± 8.0
SENNAE FOLIUM80.0 ± 2.4
SESAMI SEMEN95.7 ± 0.4
SINOMENI CAULIS ET RHIZOMA93.1 ± 4.4
SMILACIS RHIZOMA90.5 ± 1.7
SOPHORAE RADIX99.1 ± 3.9
SWERTIAE HERBA90.8 ± 4.6
TRIBULI FRUCTUS95.1 ± 1.8
TRICHOSANTHIS RADIX87.7 ± 9.2
UNCARIAE UNCIS CUM RAMULUS104.1 ± 5.8
UVAE URSI FOLIUM89 ± 6.5
VALERIANAE FAURIEI RADIX90.7 ± 6.2
ZANTHOXYLI PIPERITI PERICARPIUM82.4 ± 3.9
ZEDOARIAE RHIZOMA77.1 ± 3.7
ZINGIBERIS RHIZOMA96.8 ± 0.5
ZINGIBERIS RHIZOMA PROCESSUM79.4 ± 6.1
ZIZYPHI FRUCTUS97.7 ± 3.9
ZIZYPHI SEMEN99.7 ± 1.7

Ethanol extracts of crude drugs (20 µg/mL) were pre-incubated with cell lysates and added to fluorogenic substrates (pyr-RTKR-MCA). The data are presented as mean ± standard deviation of at least three independent experiments

Table 2

IC50 of different crud drugs

SampleIC50 (µg/mL)
Cnidii Monnieris Fructus1.10
Cnidii Rhizoma > 50
Hydrangeae Dulcis Folium7.12
Forsythiae Fructus6.52
Fig. 1

Structure and IC50 of imperatorin (1) and osthole (2)

Screening results of the inhibitory effects of 124 crude drugs on furin-like activity Ethanol extracts of crude drugs (20 µg/mL) were pre-incubated with cell lysates and added to fluorogenic substrates (pyr-RTKR-MCA). The data are presented as mean ± standard deviation of at least three independent experiments IC50 of different crud drugs Structure and IC50 of imperatorin (1) and osthole (2) In the present study, we screened the anti-furin-like activity of crude drugs using an in vitro furin-like assay with a fluorogenic substrate. Since furin is a Ca+–dependent serine protease, EDTA, a popular chelating agent was used as positive control in this screening. However, a high concentration (IC50 50 mM) was required to exert its inhibitory activities. Although polyphenols, such as tannin is known to show chelating activities, our medicinal plant extracts containing polyphenols did not show inhibitory effects on furin-like activities. It is considered that the concentration of polyphenols in our medicinal extracts was not sufficient to exhibit inhibitory activity. Of the 124 crude drugs, Cnidii Monnieris Fructus showed strong inhibitory effects on furin-like activity, and two coumarin compounds (imperatorin and osthole) exerted inhibitory activity. Further studies are required to understand if Cnidii Monnieris Fructus and its bioactive compounds block S protein processing. For example, the inhibitory effect on S protein processing could be proven if the S protein expressed in Escherichia coli is used as a cleavage substrate instead of pyr-RTKR-MCA [29]. When the S protein gene was transfected into mammalian cells, the S protein was processed by furin/PC, and syncytial phenotype was observed [5, 30]. Evaluation of S protein processing by western blotting and syncytial formation by microscopy would provide direct evidence that the samples affect S protein processing and virus entry. Osthole is a multifunctional compound with antioxidative, antiproliferative, anti-inflammatory, and antiallergic properties [31]. A recent study indicated that osthole suppressed TGF-β1-induced epithelial-mesenchymal transition (EMT) in lung cancer A549 cells [32]. Because TGF-β1 activates furin expression in several cell lines [33, 34], and proteolytic processing of the TGF-β1 precursor by furin is an essential step in the formation of biologically active TGF-β1 [35], osthole might suppress TGF-β1-induced autocrine effects by blocking furin-like activities. In conclusion, we screened the inhibitory effects of 124 crude drugs listed in the Japanese pharmacopoeia on in vitro furin-like enzymatic activities. Of these drugs, Cnidii Monnieris Fructus, which is the dried fruit of C. monnieri (Japanese name Jashoshi), strongly inhibited furin-like activity. We further isolated and identified two bioactive coumarins, imperatorin and osthole, from Cnidii Monnieris Fructus. Below is the link to the electronic supplementary material. Supplementary file1 (DOCX 17 KB)
  32 in total

1.  Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells.

Authors:  Haitao Feng; Jin-Jian Lu; Yitao Wang; Lixia Pei; Xiuping Chen
Journal:  Cell Adh Migr       Date:  2017-02-02       Impact factor: 3.405

2.  Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen.

Authors:  S S Molloy; P A Bresnahan; S H Leppla; K R Klimpel; G Thomas
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

Review 3.  Therapeutic uses of furin and its inhibitors: a patent review.

Authors:  Frédéric Couture; Anna Kwiatkowska; Yves L Dory; Robert Day
Journal:  Expert Opin Ther Pat       Date:  2015-01-07       Impact factor: 6.674

4.  Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme.

Authors:  C M Dubois; F Blanchette; M H Laprise; R Leduc; F Grondin; N G Seidah
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

5.  A second mutant allele of furin in the processing-incompetent cell line, LoVo. Evidence for involvement of the homo B domain in autocatalytic activation.

Authors:  S Takahashi; T Nakagawa; K Kasai; T Banno; S J Duguay; W J Van de Ven; K Murakami; K Nakayama
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

6.  Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus.

Authors:  Yan J Pang; Xiao J Tan; Dong M Li; Zi H Zheng; Rui X Lei; Xiao M Peng
Journal:  Liver Int       Date:  2013-04-25       Impact factor: 5.828

7.  Analysis of cathepsin and furin proteolytic enzymes involved in viral fusion protein activation in cells of the bat reservoir host.

Authors:  Farah El Najjar; Levi Lampe; Michelle L Baker; Lin-Fa Wang; Rebecca Ellis Dutch
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 8.  Phytochemistry, Ethnopharmacology, Pharmacokinetics and Toxicology of Cnidium monnieri (L.) Cusson.

Authors:  Yue Sun; Angela Wei Hong Yang; George Binh Lenon
Journal:  Int J Mol Sci       Date:  2020-02-03       Impact factor: 5.923

9.  Cell entry mechanisms of SARS-CoV-2.

Authors:  Jian Shang; Yushun Wan; Chuming Luo; Gang Ye; Qibin Geng; Ashley Auerbach; Fang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-06       Impact factor: 11.205

10.  Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.

Authors:  Ya-Wen Cheng; Tai-Ling Chao; Chiao-Ling Li; Mu-Fan Chiu; Han-Chieh Kao; Sheng-Han Wang; Yu-Hao Pang; Chih-Hui Lin; Ya-Min Tsai; Wen-Hau Lee; Mi-Hua Tao; Tung-Ching Ho; Ping-Yi Wu; Li-Ting Jang; Pei-Jer Chen; Sui-Yuan Chang; Shiou-Hwei Yeh
Journal:  Cell Rep       Date:  2020-09-23       Impact factor: 9.423

View more
  4 in total

1.  Curcumae Longae Rhizoma and Saussureae Radix Inhibit Nitric Oxide Production and Cannabinoid Receptor 2 Down-regulation.

Authors:  Takashi Tanikawa; Masashi Kitamura; Yasuhiro Hayashi; Takami Yokogawa; Yutaka Inoue
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

2.  The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro.

Authors:  Mya Myat Ngwe Tun; Kazufumi Toume; Elizabeth Luvai; Khine Mya Nwe; Shusaku Mizukami; Kenji Hirayama; Katsuko Komatsu; Kouichi Morita
Journal:  J Nat Med       Date:  2022-01-10       Impact factor: 3.192

3.  Inhibitory effect of honokiol on furin-like activity and SARS-CoV-2 infection.

Authors:  Takashi Tanikawa; Tsuyoshi Hayashi; Ryuichiro Suzuki; Masashi Kitamura; Yutaka Inoue
Journal:  J Tradit Complement Med       Date:  2021-09-16

4.  Imperatorin Positively Regulates Melanogenesis through Signaling Pathways Involving PKA/CREB, ERK, AKT, and GSK3β/β-Catenin.

Authors:  Taejin Kim; Chang-Gu Hyun
Journal:  Molecules       Date:  2022-10-02       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.